Elis Q1 Revenue Rises 4.3% via Contracts

Elis reported Q1 2026 revenue of €1.18 billion, a 4.3% YoY increase, with 3.1% organic growth.
New contract signings across all segments drove growth, with Latin America delivering nearly 10% organic growth, especially healthcare contracts in Mexico.
Acquisitions completed in 2025 added 1% to revenue, while pricing adjustments offset rising labor costs in Europe and Latin America.
Shares rose 1.5% after market open; management reaffirmed 2026 guidance for high‑single‑digit net income per share growth and modest margin improvements.